Temotrium-250 (Temozolomide Capsule) 250mg

Temotrium-250 (Temozolomide 250mg) is a chemotherapy capsule used alongside radiation for certain brain tumors. Store at 15-25°C and keep away from moisture. This overview covers uses, effects, and handling notes for patient reference.

Strength

250mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Zuvius Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Temotrium-250 is used to treat aggressive brain tumors like glioblastoma multiforme when combined with radiation therapy. It may also be prescribed for anaplastic astrocytoma in adults. This medication works by slowing or stopping tumor growth, but does not cure cancer on its own. Patients often wonder what temozolomide is used for beyond these conditions.

Side Effects

Common effects of Temotrium-250 include mild nausea, headache, or fatigue during treatment. Some patients report temporary changes in taste or appetite. These effects vary by individual and typically resolve after therapy ends. Always report persistent discomfort to your healthcare provider.

Precautions & Warnings

Keep Temotrium-250 capsules in their original packaging to protect from moisture. Use gloves when handling to avoid skin contact with powder from broken capsules. Store at room temperature (15-25°C) and keep out of reach of children. Do not open or crush capsules unless instructed by a medical professional.

Avoid Interactions

Temotrium-250 may interact with other chemotherapy drugs, valproic acid, or live vaccines. Alcohol consumption should be discussed with your doctor due to potential increased side effects. Always inform your healthcare provider about all medications and supplements you are taking before starting treatment.

Frequently Asked Questions

Temotrium-250 is primarily used to treat certain brain tumors in adults when combined with radiation therapy.

Store Temotrium-250 at room temperature (15-25°C) in a dry place, away from moisture and direct light.

Do not open or crush the capsule unless specifically instructed by your healthcare provider.

Common effects may include nausea, headache, fatigue, or changes in taste or appetite.

Yes, it may interact with certain drugs like valproic acid or live vaccines; consult your doctor before combining treatments.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.